Biotech Female Founder
AlzMed aims to create a society beyond Dementia. They socially implement research results on the mechanism of memory, develop a simple blood diagnostic method that can evaluate cognitive symptoms and treat dementia by developing drugs that prevent drebrin depletion and increase synaptic resilience.
📌 HQ: Tokyo, Japan
Together We Can Empower Global Innovation!
Enter the XTC competition
Join us to excite and impact
Help shape a better future